Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome-Reference-Cited by-同舟云学术

Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome

Published:2021-05-27 Issue:9 Volume:14 Page:1081-1089
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Siamashvili Maka¹,Davis Stephen N.¹

Affiliation:

1. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1933433

Reference53 articles.

1. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity

2. Barbieri RL, Ehrmann DA Clinical manifestations of polycystic ovary syndrome in adults. In: UpToDate; Post TW (Ed); UpToDate; Waltham; MA (Accessed on 2021 Mar 24).

3. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials;Journal of Diabetes and its Complications;2024-10

2. Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

3. Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice;Drug Design, Development and Therapy;2024-09

4. Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis;Archives of Physiology and Biochemistry;2024-07-31

5. The Impact of Polycystic Ovary Syndrome (PCOS) on the Risk of Developing Ovarian Cancer and Thyroid Disorders: A Comprehensive Review;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-04